摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Methoxycyclohexane-1,1,2,2,3-pentol

中文名称
——
中文别名
——
英文名称
3-Methoxycyclohexane-1,1,2,2,3-pentol
英文别名
——
3-Methoxycyclohexane-1,1,2,2,3-pentol化学式
CAS
——
化学式
C7H14O6
mdl
——
分子量
194.18
InChiKey
PESWSJHPBPDMCD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.6
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    110
  • 氢给体数:
    5
  • 氢受体数:
    6

文献信息

  • Methods of preventing, treating and diagnosing disorders of protein aggregation
    申请人:McLaurin, Joanne
    公开号:EP2153829A1
    公开(公告)日:2010-02-17
    Disclosed are methods of preventing, treating, or diagnosing in a subject a disorder in protein folding or aggregation., or amyloid formation., deposition, accumulation, or persistence consisting of administering to said subject a pharmaceutically effective amount of inositol stereoisomers, enantiomers or derivatives thereof.
    所公开的是预防、治疗或诊断受试者蛋白质折叠或聚集紊乱,或淀粉样蛋白形成、沉积、积累或持久性的方法,包括向所述受试者施用药学上有效量的肌醇立体异构体、对映体或其衍生物。
  • METHODS OF PREVENTING, TREATING AND DIAGNOSING DISORDERS OF PROTEIN AGGREGATION
    申请人:Ellipsis Biotherapeutics Corporation
    公开号:EP1608350A1
    公开(公告)日:2005-12-28
  • Method of preventing, treating and diagnosing disorders of protein aggregation
    申请人:McLaurin JoAnne
    公开号:US20070078099A1
    公开(公告)日:2007-04-05
    Disclosed are methods of preventing, treating, or diagnosing in a subject a disorder in protein folding or aggregation, or amyloid formation, deposition, accumulation, or persistence consisting of administering to said subject a pharmaceutically effective amount of inositol stereoisomers, enantiomers or derivatives thereof.
  • METHODS OF PREVENTING, TREATING, AND DIAGNOSING DISORDERS OF PROTEIN AGGREGATION
    申请人:McLAURIN JoAnne
    公开号:US20150164821A1
    公开(公告)日:2015-06-18
    Disclosed are methods of preventing, treating, or diagnosing in a subject a disorder in protein folding or aggregation, or amyloid formation, deposition, accumulation, or persistence consisting of administering to said subject a pharmaceutically effective amount of inositol stereoisomers, enantiomers or derivatives thereof.
  • US3982996A
    申请人:——
    公开号:US3982996A
    公开(公告)日:1976-09-28
查看更多